Home › Targets › COL7A1

COL7A1 (2 companies · 2 programs)

Companies with an active program directed at COL7A1.

Eloxx Pharmaceuticals, Inc. ELOX

ZKN-013 — Recessive Dystrophic Epidermolysis Bullosa Phase 1

Inmune Bio, Inc. INMB

CORDStrom — Recessive Dystrophic Epidermolysis Bullosa NDA Submitted